e-learning
resources
ERJ
2011
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Role of IL-1? and the Nlrp3/caspase-1/IL-1? axis in cigarette smoke-induced pulmonary inflammation and COPD
Pauwels N.S., Bracke K.R., Dupont L.L., Van Pottelberge G.R., Provoost S., Vanden Berghe T., Vandenabeele P., Lambrecht B.N., Joos G.F., Brusselle G.G.
Source:
Eur Respir J 2011; 38: 1019-1028
Journal Issue:
November
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Pauwels N.S., Bracke K.R., Dupont L.L., Van Pottelberge G.R., Provoost S., Vanden Berghe T., Vandenabeele P., Lambrecht B.N., Joos G.F., Brusselle G.G.. Role of IL-1? and the Nlrp3/caspase-1/IL-1? axis in cigarette smoke-induced pulmonary inflammation and COPD. Eur Respir J 2011; 38: 1019-1028
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Evidence-based eHealth for COPD
Related content which might interest you:
Role of lymphotoxin-alpha in cigarette smoke-induced inflammation and lymphoid neogenesis
Source: Eur Respir J 2009; 33: 405-416
Year: 2009
Role of tumour necrosis factor-α receptor p75 in cigarette smoke-induced pulmonary inflammation and emphysema
Source: Eur Respir J 2006; 28: 102-112
Year: 2006
Cigarette smoke-induced pulmonary inflammation, but not airway wall remodeling, is attenuated in CCR5 deficient mice
Source: Annual Congress 2007 - The best of airway epithelial cells
Year: 2007
Cytokine and chemokine expression in cigarette smoke-induced lung injury in guinea pigs
Source: Eur Respir J 2005; 26: 993-1001
Year: 2005
Cigarette smoke induced pulmonary emphysema is attenuated in CCR6 deficient mice
Source: Annual Congress 2006 - Cell biology of asthma and COPD
Year: 2006
Role of activin-A in cigarette smoke-induced inflammation and COPD
Source: Eur Respir J 2014; 43: 1028-1041
Year: 2014
Cigarette smoke induces peribronchial lymphoid follicles in the absence of TLR4 signalling
Source: Annual Congress 2006 - Cell biology of asthma and COPD
Year: 2006
Role of systemic inflammation mediated by IL-6 and TNF-alpha cytokines in chronic obstructive pulmonary disease and its progression: A three year follow up study
Source: Annual Congress 2013 –Systemic and airway biomarkers in respiratory diseases
Year: 2013
The NLRP3 inflammasome in chronic obstructive pulmonary disease
Source: Annual Congress 2013 –COPD: experimental biology
Year: 2013
Ceramide-1-phosphate attenuates cigarette smoke induce lung inflammation
Source: Annual Congress 2013 –Cell biology and murine models of asthma and inflammation
Year: 2013
Expression of MIC-A in bronchial epithelium associates with cigarette smoking: a sign of induced autoimmune mechanisms?
Source: Annual Congress 2005 - Lung structure: current concepts
Year: 2005
P2RX4 signalling enhances acute cigarette smoke-induced lung inflammation and chronic lung emphysema development
Source: International Congress 2019 – Airway inflammation: pharmacological mechanisms and novel targets
Year: 2019
Aclidinium inhibits cigarette smoke-induced lung fibroblast-to-myofibroblast transition
Source: Eur Respir J 2013; 41: 1264-1274
Year: 2013
Cigarette smoke-induced emphysema occurs in the absence of TLR4-signalling in a murine model of COPD
Source: Annual Congress 2008 - Best of lung epithelial cells 2008
Year: 2008
Involvement of MMP-12 and phosphodiesterase type 4 in cigarette smoke-induced inflammation in mice
Source: Eur Respir J 2006; 27: 1102-1109
Year: 2006
Characterisation of a sub-acute mouse model of cigarette smoke extract-induced lung inflammation
Source: Annual Congress 2007 - The best of airway epithelial cells
Year: 2007
Cryptotanshinone attenuates airway Inflammation induced by cigarette smoke in mice
Source: International Congress 2016 – New signalling pathways in COPD
Year: 2016
Role of IL-1α and IL-1β in cigarette smoke-induced pulmonary inflammation and COPD
Source: Annual Congress 2011 - COPD: clinical studies and animal cell models
Year: 2011
Involvement of NCOA4-mediated ferritinophagy in cigarette smoke-induced ferroptosis in COPD pathogenesis
Source: International Congress 2018 – New kids on the block: novel molecular pathways and therapeutic targets in chronic lung diseases
Year: 2018
Genetic susceptibility to chronic obstructive pulmonary disease
Source: ISSN=ISSN 1025-448x, ISBN=ISBN 1-904097-48-0, page=84
Year: 2006
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept